These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3615193)

  • 41. [Morphometric study on the megakaryocyte in various platelet disorders].
    Ihzumi T
    Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):758-71. PubMed ID: 6475467
    [No Abstract]   [Full Text] [Related]  

  • 42. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia.
    Pathansali R; Smith N; Bath P
    Platelets; 2001 Aug; 12(5):292-7. PubMed ID: 11487381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelofibrosis and acute megakaryoblastic leukemia in a child: topographic relationship between fibroblasts and megakaryocytes with an alpha-granule defect.
    Breton-Gorius J; Bizet M; Reyes F; Dupuy E; Mear C; Vannier JP; Tron P
    Leuk Res; 1982; 6(1):97-110. PubMed ID: 6461801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The York platelet syndrome: a fourth case with unusual pathologic features.
    White JG; Pakzad K; Meister L
    Platelets; 2013; 24(1):44-50. PubMed ID: 22757654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric analysis of megakaryocytes (Mks) from patients with platelet disorders.
    Conklin RJ; Tomer A; Friese P; Bales W; Burstein SA
    Prog Clin Biol Res; 1990; 356():303-17. PubMed ID: 2217446
    [No Abstract]   [Full Text] [Related]  

  • 46. [Myelofibrosis associated with immunological abnormalities].
    Makishima M; Yamamoto K; Motoyoshi K; Nagata N; Takatani O; Matsuura Y; Fuse Y
    Rinsho Ketsueki; 1990 Jul; 31(7):1008-12. PubMed ID: 2214180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
    Romano M; Viero P; Cortellazzo S; Barbui T; Donati MB; Poggi A
    Haemostasis; 1990; 20(3):162-8. PubMed ID: 2143744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A dominant-negative GFI1B mutation in the gray platelet syndrome.
    Monteferrario D; Bolar NA; Marneth AE; Hebeda KM; Bergevoet SM; Veenstra H; Laros-van Gorkom BA; MacKenzie MA; Khandanpour C; Botezatu L; Fransen E; Van Camp G; Duijnhouwer AL; Salemink S; Willemsen B; Huls G; Preijers F; Van Heerde W; Jansen JH; Kempers MJ; Loeys BL; Van Laer L; Van der Reijden BA
    N Engl J Med; 2014 Jan; 370(3):245-53. PubMed ID: 24325358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.
    Guerrero JA; Bennett C; van der Weyden L; McKinney H; Chin M; Nurden P; McIntyre Z; Cambridge EL; Estabel J; Wardle-Jones H; Speak AO; Erber WN; Rendon A; Ouwehand WH; Ghevaert C
    Blood; 2014 Dec; 124(24):3624-35. PubMed ID: 25258341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet acquired defect in PDGF and beta thromboglobulin content in hairy cell leukaemia: improvement after interferon therapy.
    Dupuy E; Sigaux F; Bryckaert MC; Tobelem G; Castaigne S; Flandrin G; Degos L; Caen JP
    Br J Haematol; 1987 Jan; 65(1):107-10. PubMed ID: 2949773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of human megakaryocyte coagulation factor V.
    Nichols WL; Gastineau DA; Solberg LA; Mann KG
    Blood; 1985 Jun; 65(6):1396-406. PubMed ID: 2581640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simultaneous occurrence of grey platelet syndrome and idiopathic pulmonary fibrosis: a role for abnormal megakaryocytes in the pathogenesis of pulmonary fibrosis?
    Facon T; Goudemand J; Caron C; Zandecki M; Estienne MH; Fenaux P; Cosson A
    Br J Haematol; 1990 Apr; 74(4):542-3. PubMed ID: 2346734
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats.
    Yanagida M; Ide Y; Imai A; Toriyama M; Aoki T; Harada K; Izumi H; Uzumaki H; Kusaka M; Tokiwa T
    Br J Haematol; 1997 Dec; 99(4):739-45. PubMed ID: 9432016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Does platelet derived growth factor induce myelofibrosis in agnogenic myeloid metaplasia?].
    Teplizky H; Dvilansky A
    Harefuah; 1987 Jan; 112(2):102-4. PubMed ID: 3596376
    [No Abstract]   [Full Text] [Related]  

  • 55. Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis.
    Eastham JM; Reilly JT; Mac Neil S
    Br J Haematol; 1994 Mar; 86(3):668-70. PubMed ID: 8043453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.
    Zetterberg E; Verrucci M; Martelli F; Zingariello M; Sancillo L; D'Amore E; Rana RA; Migliaccio AR
    Platelets; 2014; 25(7):539-47. PubMed ID: 24176039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis.
    Schmitt A; Drouin A; Massé JM; Guichard J; Shagraoui H; Cramer EM
    Leuk Lymphoma; 2002 Apr; 43(4):719-24. PubMed ID: 12153156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis.
    Desterke C; Martinaud C; Guerton B; Pieri L; Bogani C; Clay D; Torossian F; Lataillade JJ; Hasselbach HC; Gisslinger H; Demory JL; Dupriez B; Boucheix C; Rubinstein E; Amsellem S; Vannucchi AM; Le Bousse-Kerdilès MC
    Haematologica; 2015 Jun; 100(6):757-67. PubMed ID: 25840601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.
    Kurimoto M; Nishijima M; Hirashima Y; Endo S; Takaku A
    Acta Neurochir (Wien); 1995; 137(3-4):182-7. PubMed ID: 8789659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thrombocytopathy associated with nonleukemic megakaryocytic myelosis. Functional and fine structure observations of the abnormal platelets.
    Taylor DD; Senhauser DA; Cavazos F
    Am J Clin Pathol; 1968 May; 49(5):662-70. PubMed ID: 5660961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.